Antithrombotic Therapy in Patients Undergoing Percutaneous Left Atrial Appendage Occlusion.
Interv Cardiol Clin
; 13(4): 543-552, 2024 Oct.
Article
en En
| MEDLINE
| ID: mdl-39245553
ABSTRACT
Percutaneous left atrial appendage closure (LAAC) is a valid alternative to oral anticoagulation to prevent ischemic stroke in patients with atrial fibrillation.The devices approved in Europe and United States for percutaneous LAAC contain metal and temporary antithrombotic therapy is strongly recommended following implantation to prevent thrombus formation on the atrial device surface. There is still uncertainty regarding to the optimal antithrombotic drug regimen after device implantation for several reasons. Thus, this review aims at summarizing the available evidence and the remaining challenges related to the management of antithrombotic therapy in the context of LAAC procedure.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Fibrilación Atrial
/
Apéndice Atrial
/
Fibrinolíticos
Límite:
Humans
Idioma:
En
Revista:
Interv Cardiol Clin
Año:
2024
Tipo del documento:
Article
Pais de publicación:
Países Bajos